FDA votes for stronger Yasmin, Yaz warnings
A Food and Drug Administration panel of experts voted that the manufacturer of Yaz and Yasmin should update warning labels to include information from new studies about the side effects of the drugs. The panel agreed that Bayer’s current warning labels are inadequate and should contain new information concerning the increased risk of blood clots [...]
Official says Bayer withheld Yasmin safety information from FDA
The former commissioner of the Food and Drug Administration said that Bayer withheld important safety information concerning its birth control pill Yasmin. In a document unsealed in court, David Kessler said the company left out an important study on the pill’s side effects in information provided to the agency.
FDA considers stronger Yasmin, Yaz blood clots warning
The Food and Drug Administration has announced that it may issue a new warning about the risk of blood clots for women taking the birth control pills Yaz and Yasmin. The agency plans to hold a hearing with outside experts to weigh whether some women should not be prescribed these drugs due to the potential [...]
Yasmin, Yaz lawsuits allege maker withheld safety information
Yasmin and Yaz lawsuits filed in Illinois and Pennsylvania allege that the manufacturer of the birth control pills withheld safety information from consumers. More than 10,000 lawsuits alleging Yaz and Yasmin injured patients have been filed against Bayer.
Maker of Yaz, Yasmin may have illegally promoted drugs
The maker of the birth control pills Yaz and Yasmin may have promoted the drugs for off-label use, according to company emails obtained by lawyers pursuing Yasmin and Yaz lawsuits. More than 10,000 lawsuits have been filed against Bayer alleging the drugs caused injuries to the patients.
Study finds Yaz, Yasmin raise blood clots risk
A nine-year study has linked newer birth control pills including Yaz and Yasmin to an increased risk of potentially dangerous blood clots. The Danish study of more than 1.3 million women found that drugs such as Yaz and Yasmin could increase the risk of venous thromboembolism, a condition in which clots form in the lower [...]
FDA plans December meeting to discuss Yaz and Yasmin risks
The Food and Drug Administration plans to meet in December to discuss its policy and new findings on Yaz and Yasmin. The FDA plans to meet with a panel of medical experts on Dec. 8 to discuss the findings of a new study about the side effects of Yaz and Yasmin.
Yaz, Yasmin may triple blood clots risk, FDA says
The Food and Drug Administration has warned that the use of birth control pills such as Yaz and Yasmin can double or triple the risk of blood clots compared to another widely-used form of birth control.
Studies show Yaz, Yasmin double blood clot risk
Two studies published in the British Medical Journal have found that women taking Yaz or Yasmin birth control pills are two to three times more likely to suffer blood clots than women who use older birth control brands. This increased blood clot risk could place women in danger of other serious side effects, including pulmonary [...]
Class action Yaz, Yasmin lawsuit filed in Canada
Lawyers in Canada filed a class action lawsuit in November 2010 against the manufacturer of the birth control pills Yaz or Yasmin. The lawsuit was filed on behalf of Canadian women who used Yaz or Yasmin and suffered blood clots or other side effects from these drugs.